Related references
Note: Only part of the references are listed.In Vitro Pharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii
Mao Hagihara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital
Mei Deng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Efficacy and Safety Profile Comparison of Colistin and Tigecycline on the Extensively Drug Resistant Acinetobacter baumannii
Sung Hee Kwon et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
Effect of Proton Pump Inhibitors on In Vitro Activity of Tigecycline against Several Common Clinical Pathogens
Wentao Ni et al.
PLOS ONE (2014)
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
Gennaro De Pascale et al.
CRITICAL CARE (2014)
Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant Acinetobacter baumannii Sepsis
Gokcen Dinc et al.
CHEMOTHERAPY (2013)
Distribution of Allelic Variants of the Chromosomal Gene bla OXA-114-like in Achromobacter xylosoxidans Clinical Isolates
German Matias Traglia et al.
CURRENT MICROBIOLOGY (2013)
Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections
Yen-Hsu Chen et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art
Remy A. Bonnin et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III
Maria Silvina Stietz et al.
INFECTION GENETICS AND EVOLUTION (2013)
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Raffaele Zarrilli et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Pan-PCR, a Computational Method for Designing Bacterium-Typing Assays Based on Whole-Genome Sequence Data
Joy Y. Yang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: Susceptibility and clinical outcome
Nak-Hyun Kim et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp.
Sebastien Coyne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Overexpression of the adeB Gene in Clinical Isolates of Tigecycline-Nonsusceptible Acinetobacter baumannii without Insertion Mutations in adeRS
Jun-Ren Sun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vivo Selection of a Missense Mutation in adeR and Conversion of the Novel blaOXA-164 Gene into blaOXA-58 in Carbapenem-Resistant Acinetobacter baumannii Isolates from a Hospitalized Patient
Paul G. Higgins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan
Jien-Wei Liu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods
Chun-Hsing Liao et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system
I Marchand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Share Paper
